Vetoquinol SA
PAR:VETO

Watchlist Manager
Vetoquinol SA Logo
Vetoquinol SA
PAR:VETO
Watchlist
Price: 83 EUR -1.78% Market Closed
Market Cap: 982m EUR
Have any thoughts about
Vetoquinol SA?
Write Note

Intrinsic Value

The intrinsic value of one VETO stock under the Base Case scenario is 86.88 EUR. Compared to the current market price of 83 EUR, Vetoquinol SA is Undervalued by 4%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

VETO Intrinsic Value
86.88 EUR
Undervaluation 4%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Vetoquinol SA

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for VETO cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about VETO?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Pharmaceuticals Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Vetoquinol SA

Provide an overview of the primary business activities
of Vetoquinol SA.

What unique competitive advantages
does Vetoquinol SA hold over its rivals?

What risks and challenges
does Vetoquinol SA face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Vetoquinol SA.

Provide P/S
for Vetoquinol SA.

Provide P/E
for Vetoquinol SA.

Provide P/OCF
for Vetoquinol SA.

Provide P/FCFE
for Vetoquinol SA.

Provide P/B
for Vetoquinol SA.

Provide EV/S
for Vetoquinol SA.

Provide EV/GP
for Vetoquinol SA.

Provide EV/EBITDA
for Vetoquinol SA.

Provide EV/EBIT
for Vetoquinol SA.

Provide EV/OCF
for Vetoquinol SA.

Provide EV/FCFF
for Vetoquinol SA.

Provide EV/IC
for Vetoquinol SA.

Show me price targets
for Vetoquinol SA made by professional analysts.

What are the Revenue projections
for Vetoquinol SA?

How accurate were the past Revenue estimates
for Vetoquinol SA?

What are the Net Income projections
for Vetoquinol SA?

How accurate were the past Net Income estimates
for Vetoquinol SA?

What are the EPS projections
for Vetoquinol SA?

How accurate were the past EPS estimates
for Vetoquinol SA?

What are the EBIT projections
for Vetoquinol SA?

How accurate were the past EBIT estimates
for Vetoquinol SA?

Compare the revenue forecasts
for Vetoquinol SA with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Vetoquinol SA and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Vetoquinol SA against its competitors.

Analyze the profit margins
(gross, operating, and net) of Vetoquinol SA compared to its peers.

Compare the P/E ratios
of Vetoquinol SA against its peers.

Discuss the investment returns and shareholder value creation
comparing Vetoquinol SA with its peers.

Analyze the financial leverage
of Vetoquinol SA compared to its main competitors.

Show all profitability ratios
for Vetoquinol SA.

Provide ROE
for Vetoquinol SA.

Provide ROA
for Vetoquinol SA.

Provide ROIC
for Vetoquinol SA.

Provide ROCE
for Vetoquinol SA.

Provide Gross Margin
for Vetoquinol SA.

Provide Operating Margin
for Vetoquinol SA.

Provide Net Margin
for Vetoquinol SA.

Provide FCF Margin
for Vetoquinol SA.

Show all solvency ratios
for Vetoquinol SA.

Provide D/E Ratio
for Vetoquinol SA.

Provide D/A Ratio
for Vetoquinol SA.

Provide Interest Coverage Ratio
for Vetoquinol SA.

Provide Altman Z-Score Ratio
for Vetoquinol SA.

Provide Quick Ratio
for Vetoquinol SA.

Provide Current Ratio
for Vetoquinol SA.

Provide Cash Ratio
for Vetoquinol SA.

What is the historical Revenue growth
over the last 5 years for Vetoquinol SA?

What is the historical Net Income growth
over the last 5 years for Vetoquinol SA?

What is the current Free Cash Flow
of Vetoquinol SA?

Discuss the annual earnings per share (EPS)
trend over the past five years for Vetoquinol SA.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Vetoquinol SA

Current Assets 383.5m
Cash & Short-Term Investments 162.8m
Receivables 96.3m
Other Current Assets 124.3m
Non-Current Assets 323m
Long-Term Investments 1.6m
PP&E 87.6m
Intangibles 223.7m
Other Non-Current Assets 10m
Current Liabilities 138.8m
Accounts Payable 118.6m
Other Current Liabilities 20.2m
Non-Current Liabilities 24.6m
Long-Term Debt 9.7m
Other Non-Current Liabilities 14.9m
Efficiency

Earnings Waterfall
Vetoquinol SA

Revenue
537.5m EUR
Cost of Revenue
-275.1m EUR
Gross Profit
262.3m EUR
Operating Expenses
-197.6m EUR
Operating Income
64.7m EUR
Other Expenses
-17.6m EUR
Net Income
47.1m EUR

Free Cash Flow Analysis
Vetoquinol SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

VETO Profitability Score
Profitability Due Diligence

Vetoquinol SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive 3-Year Average ROIC
Positive Operating Income
56/100
Profitability
Score

Vetoquinol SA's profitability score is 56/100. The higher the profitability score, the more profitable the company is.

VETO Solvency Score
Solvency Due Diligence

Vetoquinol SA's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Long-Term Solvency
Negative Net Debt
96/100
Solvency
Score

Vetoquinol SA's solvency score is 96/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

VETO Price Targets Summary
Vetoquinol SA

Wall Street analysts forecast VETO stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for VETO is 104.21 EUR with a low forecast of 94.94 EUR and a high forecast of 126 EUR.

Lowest
Price Target
94.94 EUR
14% Upside
Average
Price Target
104.21 EUR
26% Upside
Highest
Price Target
126 EUR
52% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for VETO?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for VETO is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Vetoquinol SA Logo
Vetoquinol SA

Country

France

Industry

Pharmaceuticals

Market Cap

1 000m EUR

Dividend Yield

1.02%

Description

Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.

Contact

BOURGOGNE-FRANCHE-COMTE
Lure
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
+33384625555.0
www.vetoquinol.com

IPO

2006-11-16

Employees

2 400

Officers

Deputy CEO & Pharmacist Manager
Mr. Alain Masson
CEO & Non-Independent Chairman of the Board
Mr. Matthieu Frechin
Chief Financial Officer
Mr. Regis Vimal du Monteil
Chief Operations Officer
Mr. Dominique Derveaux
Chief Scientific Officer
Philippe Gruet
Chief Information Officer
Sandrine Perrier
Show More
Director of Partnerships, Legal Affairs & Risks
Laurent Thore
Director of Group Communications
Xavier Berthet
Group Director of Human Resources
Ms. Isabelle Proust-Cabrera
Show Less

See Also

Discover More
What is the Intrinsic Value of one VETO stock?

The intrinsic value of one VETO stock under the Base Case scenario is 86.88 EUR.

Is VETO stock undervalued or overvalued?

Compared to the current market price of 83 EUR, Vetoquinol SA is Undervalued by 4%.

Back to Top